Live data from Hacker News

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)

ncbi.nlm.nih.gov

1–10 of 23 posts

Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)

#5
The title is shortened in a somewhat misleading way, making it sound at if this might be about a clinical study.

The full title is: "Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease."

What this is is a study performed in mice, trying to work out the mechanism of action of Remdesivir, which is known to inhibit SARS-CoV-2 in vitro.

What's going to be really interesting is what comes out of ongoing clinical studies: https://www.gilead.com/purpose/advancing-global-health/covid...

Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)

#6

Anyone with actual knowledge know the state of ACE2 inhibitor and chloroquinine efficacy?

No actual knowledge, but apparently the way Coronaviruses kill your lung cells is by inhibiting their ACE2 receptors, so I doubt taking an additional ACE2 inhibitor would be helpful. C.f.:

https://www.stephenharrodbuhner.com/wp-content/uploads/2020/...

Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)

#7

Anyone with actual knowledge know the state of ACE2 inhibitor and chloroquinine efficacy?

Well, the Chinese claim chloroquine is effective in domestic RCT.

And since China seems to be light years ahead of CDC/FDA, I'm inclined to believe them.

Post reply on HN